Although these data need further experimental evaluation, it seems likely that, similar to ovarian cancer, 1‐MNA acts as an immune‐suppressive metabolite in ccRCC, suggesting a dual effect of NNMT inhibition in ccRCC. The gene discussed is NNMT; the disease is ovarian carcinoma.